Regenxbio (RGNX) Profit After Tax (2014 - 2025)

Regenxbio's Profit After Tax history runs 12 years deep, the most recent figure standing at -$67.1 million for Q4 2025.

• In Q4 2025, Profit After Tax fell 31.19% year-over-year to -$67.1 million; the TTM figure through Dec 2025 stood at -$193.9 million (up 14.63% YoY), while the FY2025 annual figure was -$193.9 million, up 14.63% from the prior year.
• Profit After Tax was -$67.1 million for Q4 2025 at Regenxbio, down from -$61.9 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $294.0 million in Q4 2021 to a low of -$76.7 million in Q1 2022.
• Historically, Profit After Tax has averaged -$41.8 million across 5 years, with a median of -$61.9 million in 2023.
• Biggest YoY gain for Profit After Tax was 735.85% in 2021; the steepest drop was 764.37% in 2021.
• A 5-year view of Profit After Tax shows it stood at $294.0 million in 2021, then tumbled by 120.38% to -$59.9 million in 2022, then slipped by 4.93% to -$62.9 million in 2023, then increased by 18.61% to -$51.2 million in 2024, then slumped by 31.19% to -$67.1 million in 2025.
• The last three Profit After Tax figures came in at -$67.1 million (Q4 2025), -$61.9 million (Q3 2025), and -$70.9 million (Q2 2025), per Business Quant data.